4553: Towa Pharmaceutical Co., Ltd. - Summary | Jitta

Towa Pharmaceutical Co., Ltd.

TYO:4553

Price
¥3,960.00
Loss Chance
43.1%
5.54JITTA SCORE
75.81%Under Jitta Line
Jitta Ranking
13 / 184
360 / 3,520
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (62)
Recent Business Performance (61)
Financial Strength (54)
Return to Shareholders (49)
Competitive Advantage (68)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Year
Dividend PayoutIncreasing Every Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Operating MarginInconsistent
Debt LevelVery High Long Term Debt
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.54
75.81%
4.56
100.25%
4.42
342.61%
Pharmaceuticals
6.80
24.39%
6.52
34.49%
6.77
26.90%
COMPANY DESCRIPTION
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.